The price of SpringWorks Therapeutics Inc (NASDAQ: SWTX) closed at $44.22 in the last session, up 0.36% from day before closing price of $44.06. In other words, the price has increased by $+0.16 from its previous closing price. On the day, 548567 shares were traded.
Ratios:
We take a closer look at SWTX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.37 and its Current Ratio is at 6.41. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Guggenheim on February 05, 2024, initiated with a Buy rating and assigned the stock a target price of $75.
On December 01, 2022, BofA Securities started tracking the stock assigning a Buy rating and target price of $45.
H.C. Wainwright reiterated its Buy rating for the stock on January 19, 2021, while the target price for the stock was revised from $87 to $101.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 16 ’24 when Pichl Daniel sold 15,000 shares for $50.10 per share. The transaction valued at 751,550 led to the insider holds 45,212 shares of the business.
Ashar Bhavesh sold 4,834 shares of SWTX for $238,435 on Feb 05 ’24. The Chief Commercial Officer now owns 58,154 shares after completing the transaction at $49.32 per share. On Feb 02 ’24, another insider, Pichl Daniel, who serves as the Chief People Officer of the company, sold 26,181 shares for $44.32 each. As a result, the insider received 1,160,362 and left with 45,212 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SWTX now has a Market Capitalization of 3.27B and an Enterprise Value of 2.80B. For the stock, the TTM Price-to-Sale (P/S) ratio is 598.71 while its Price-to-Book (P/B) ratio in mrq is 5.19. Its current Enterprise Value per Revenue stands at 514.56 whereas that against EBITDA is -8.21.
Stock Price History:
Over the past 52 weeks, SWTX has reached a high of $53.92, while it has fallen to a 52-week low of $18.00. The 50-Day Moving Average of the stock is 48.24, while the 200-Day Moving Average is calculated to be 33.28.
Shares Statistics:
According to the various share statistics, SWTX traded on average about 1.15M shares per day over the past 3-months and 754.66k shares per day over the past 10 days. A total of 73.49M shares are outstanding, with a floating share count of 63.10M. Insiders hold about 14.48% of the company’s shares, while institutions hold 91.44% stake in the company. Shares short for SWTX as of Mar 15, 2024 were 11.17M with a Short Ratio of 9.74, compared to 11.41M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 15.14% and a Short% of Float of 17.83%.
Earnings Estimates
The company has 6 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$1.19 for the current quarter, with a high estimate of -$0.93 and a low estimate of -$1.35, while EPS last year was -$1.18. The consensus estimate for the next quarter is $1.75, with high estimates of $16.1 and low estimates of -$1.33.
Analysts are recommending an EPS of between -$3.05 and -$5.97 for the fiscal current year, implying an average EPS of -$4.71. EPS for the following year is -$3.5, with 5 analysts recommending between -$0.47 and -$4.42.
Revenue Estimates
A total of 8 analysts have provided revenue estimates for SWTX’s current fiscal year. The highest revenue estimate was $127.7M, while the lowest revenue estimate was $54.2M, resulting in an average revenue estimate of $87.34M. In the same quarter a year ago, actual revenue was $5.45M, up 1,503.50% from the average estimate. Based on 6 analysts’ estimates, the company’s revenue will be $256.3M in the next fiscal year. The high estimate is $376.4M and the low estimate is $190.3M. The average revenue growth estimate for next year is up 193.50% from the average revenue estimate for this year.
